Cited by 177HIV Research and TreatmentHIV/AIDS drug development and treatmentInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

HIV reservoirs: pathogenesis and obstacles to viral eradication and cure

Chun, Tae-Wook, Fauci, Anthony S.·2012·AIDS

Open this paper in CoChat — free account

Abstract

Plasma HIV viremia can be suppressed and maintained below the limits of detection for prolonged periods of time in the vast majority of HIV-infected individuals who receive antiretroviral therapy (ART). Thus, the clinical outcome for HIV-infected individuals who have access to these drugs is dramatically improved. However, ART alone cannot eradicate HIV in infected individuals and this impediment is likely in part due to the persistence of viral reservoirs in the peripheral blood and lymphoid tissues of infected individuals despite the suppression of plasma viremia. In recent years, major research efforts have been dedicated to a better understanding of the pathogenesis of persistent HIV infection and to the development of therapeutic strategies aimed at eradicating virus in infected individuals receiving ART. In this review, we discuss the pathophysiology of CD4 T-cell HIV reservoirs, including recent advances in our understanding of the mechanisms of persistent viral infection and perspectives for eradication of HIV in infected individuals.

Integrity signals

Registry

Crossref · 10.1097/qad.0b013e328353f3f1

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M. H., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,533
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
Hammer, S. M., Squires, K., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J., Balfour, H. H., Deyton, L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,638
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050
Self-citation
An inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G. J., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,019
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T., Stuyver, L. J., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,960
Self-citation
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
Gulick, R. M., Mellors, J. W., Havlir, D. V., Eron, J. J., Gonzalez, C. J., McMahon, D. K., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,883

Show all 99 references

Sorted by citations

Immune clearance of highly pathogenic SIV infection
Hansen, S. G., Piatak, M., Ventura, A. B., Hughes, C. M., Gilbride, R. M., Ford, J. C., Oswald, K. A., Shoemaker, R. S., Li, Y., Lewis, M. S., et al. (2013) · Nature · doi:10.1038/nature12519 · Cited by 598
RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
Hu, W., Kaminski, R., Yang, F., Zhang, Y., Cosentino, L., Li, F., Luo, B., Alvarez-Carbonell, D., Garcia-Mesa, Y., Karn, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405186111 · Cited by 527
Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques
Santangelo, P. J., Rogers, K. A., Zurla, C., Blanchard, E. L., Gumber, S., Strait, K. R., Connor‐Stroud, F., Schuster, D. M., Amancha, P. K., Hong, J. J., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3320 · Cited by 167
The Y chromosome: a blueprint for men’s health?
Maan, A., Eales, J., Akbarov, A., Rowland, J., Xu, X., Jobling, M. A., Charchar, F. J., & Tomaszewski, M. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.128 · Cited by 172
Pathogenesis of HIV infection
Naif, H. M. (2013) · Infectious Disease Reports · doi:10.4081/idr.2013.s1.e6 · Cited by 160
Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy
Pallikkuth, S., Sharkey, M. E., Babič, D. Z., Gupta, S., Stone, G. W., Fischl, M. A., Stevenson, M., & Pahwa, S. G. (2015) · Journal of Virology · doi:10.1128/jvi.02883-15 · Cited by 130
MicroRNAs and HIV-1 Infection: Antiviral Activities and Beyond
Swaminathan, G., Navas, S., & Martín‐García, J. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.12.017 · Cited by 116
Cellular and molecular mechanisms involved in the establishment of HIV-1 latency
Donahue, D. A., & Wainberg, M. A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-11 · Cited by 117
Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis
Campos, N., Myburgh, R., Garcel, A., Vautrin, A., Lapasset, L., Nadal, E. S., Mahuteau‐Betzer, F., Najman, R., Fornarelli, P., Tantale, K., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0159-3 · Cited by 101
Activation and lysis of human CD4 cells latently infected with HIV-1
Pegu, A., Asokan, M., Wu, L., Wang, K., Hataye, J. M., Casazza, J. P., Guo, X., Shi, W., Georgiev, I. S., Zhou, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms9447 · Cited by 100
Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10
Irimia, A., Sarkar, A., Stanfield, R. L., & Wilson, I. A. (2016) · Immunity · doi:10.1016/j.immuni.2015.12.001 · Cited by 103
Nucleolar protein NOP2/NSUN1 suppresses HIV-1 transcription and promotes viral latency by competing with Tat for TAR binding and methylation
Kong, W., Biswas, A., Zhou, D., Fiches, G. N., Fujinaga, K., Santoso, N. G., & Zhu, J. K. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008430 · Cited by 94
Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain
Roy, U. B., Drozd, V., Durygin, A., Rodríguez, J. C. D., Barber, P., Atluri, V. S. R., Liu, X., Voss, T. G., Saxena, S. K., & Nair, M. (2018) · Scientific Reports · doi:10.1038/s41598-017-16703-9 · Cited by 94
EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment
Gu, C., Borjabad, A., Hadas, E., Kelschenbach, J., Kim, B., Chao, W., Arancio, O., Suh, J., Polsky, B., McMillan, J., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007061 · Cited by 92
Cellular and molecular mechanisms of HIV-1 integration targeting
Engelman, A., & Singh, P. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2772-5 · Cited by 102
Extracellular Vesicles in the Pathogenesis of Viral Infections in Humans
Caobi, A., Nair, M., & Raymond, A. (2020) · Viruses · doi:10.3390/v12101200 · Cited by 88
Toward an AIDS-Free Generation
Fauci, A. S., & Folkers, G. K. (2012) · JAMA · doi:10.1001/jama.2012.8142 · Cited by 87
Self-citation
HIV-1 Latency: An Update of Molecular Mechanisms and Therapeutic Strategies
Battistini, A., & Sgarbanti, M. (2014) · Viruses · doi:10.3390/v6041715 · Cited by 86
Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection
Puertas, M. C., Massanella, M., Llibre, J. M., Ballestero-Téllez, M., Buzón, M. J., Ouchi, D., Esteve, A., Boix, J., Manzardo, C., Miró, J. M., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000066 · Cited by 78
The search for an HIV cure: tackling latent infection
Kent, S. J., Reece, J. C., Petravic, J., Martyushev, A., Kramski, M., Rose, R. D., Cooper, D. A., Kelleher, A. D., Emery, S., Cameron, P. U., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70043-4 · Cited by 71
What Integration Sites Tell Us about HIV Persistence
Hughes, S. H., & Coffin, J. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.04.010 · Cited by 74
Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir
Chun, T., Murray, D., Justement, J. S., Blažková, J., Hallahan, C. W., Fankuchen, O., Gittens, K. R., Benko, E., Kovacs, C. M., Moir, S. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414148111 · Cited by 69
Self-citation
The Detection and Management of Early HIV Infection
Smith, M. K., Rutstein, S. E., Powers, K. A., Fidler, S. J., Miller, W. C., Eron, J. J., & Cohen, M. S. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31829871e0 · Cited by 59
Immune surveillance and response to JC virus infection and PML
Beltrami, S., & Gordon, J. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-013-0222-6 · Cited by 59
On HIV diversity
Ndung’u, T., & Weiss, R. A. (2012) · AIDS · doi:10.1097/qad.0b013e32835461b5 · Cited by 56
The human Papillomavirus twilight zone – Latency, immune control and subclinical infection
Doorbar, J. (2023) · Tumour Virus Research · doi:10.1016/j.tvr.2023.200268 · Cited by 56
The Ambiguous Roles of Extracellular Vesicles in HIV Replication and Pathogenesis
Dias, M. V. S., Costa, C. S., & daSilva, L. L. P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02411 · Cited by 59
Cell–cell contact viral transfer contributes to HIV infection and persistence in astrocytes
Luo, X., & He, J. J. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0304-0 · Cited by 56
Prevalence and Predictors of Immunological Failure among HIV Patients on HAART in Southern Ethiopia
Yirdaw, K. D., & Hattingh, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125826 · Cited by 52
HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell
Boullé, M., Müller, T. G., Dähling, S., Ganga, Y., Jackson, L., Mahamed, D., Lance, O., Lustig, G., Neher, R. A., & Sigal, A. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005964 · Cited by 52
Recruitment and ethical considerations in HIV cure trials requiring treatment interruption
Arnold, M. P., Evans, D., & Vergel, N. (2015) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)31148-1 · Cited by 50
Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication
Shkreta, L., Blanchette, M., Toutant, J., Wilhelm, E., Bell, B., Story, B. A., Balachandran, A., Cochrane, A., Cheung, P. K., Harrigan, P. R., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1223 · Cited by 48
The HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind’s future?
de Groot, N. G., & Bontrop, R. E. (2013) · Retrovirology · doi:10.1186/1742-4690-10-53 · Cited by 46
HIV-1, interferon and the interferon regulatory factor system: An interplay between induction, antiviral responses and viral evasion
Marsili, G., Remoli, A. L., Sgarbanti, M., Perrotti, E., Fragale, A., & Battistini, A. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.06.001 · Cited by 52
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption
Chang-yi, W., Wong, W.-W., Tsai, H., Chen, Y., Kuo, B.-S., Lynn, S., Blažková, J., Clarridge, K. E., Su, H.-W., Lin, C.-Y., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1802264 · Cited by 45
Self-citation
An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses
Wells, D., Guo, S., Shao, W., Bale, M. J., Coffin, J. M., Hughes, S. H., & Wu, X. (2020) · BMC Genomics · doi:10.1186/s12864-020-6647-4 · Cited by 46
3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H
Wu, B., Tang, J. Y., Wilson, D. J., Huber, A. D., Casey, M. C., Ji, J., Kankanala, J., Xie, J., Sarafianos, S. G., & Wang, Z. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00040 · Cited by 44
Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates
Mikulak, J., Vito, C. D., Zaghi, E., & Mavilio, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00314 · Cited by 43
An open-label phase 1 clinical trial of the anti-α 4 β 7 monoclonal antibody vedolizumab in HIV-infected individuals
Sneller, M. C., Clarridge, K. E., Seamon, C. A., Shi, V., Zorawski, M. D., Justement, J. S., Blažková, J., Huiting, E. D., Proschan, M. A., Mora, J. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax3447 · Cited by 43
Self-citation
Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments
Arias, A., López, P. L., Sánchez, R., Yamamura, Y., & Rivera‐Amill, V. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081697 · Cited by 41
Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase
Gu, S., Xue, P., Ju, X.-L., & Zhu, Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.025 · Cited by 40
Effect of the Latent Reservoir on the Evolution of HIV at the Within- and Between-Host Levels
Doekes, H. M., Fraser, C., & Lythgoe, K. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005228 · Cited by 43
Delayed Emergence of HIV-1 Variants Resistant to 4′-Ethy Nyl-2-Fluoro-2′-Deoxyadenosine: Comparative Sequential Passage Study with Lamivudine, Tenofovir, Emtricitabine and BMS-986001
Maeda, K., Desai, D. V., Aoki, M., Nakata, H., Kodama, E. N., & Mitsuya, H. (2013) · Antiviral Therapy · doi:10.3851/imp2697 · Cited by 38
Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function
Wong, R., Balachandran, A., Haaland, M., Stoilov, P., & Cochrane, A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt727 · Cited by 37
Immune modulatory capacity of probiotic lactic acid bacteria and applications in vaccine development
Mojgani, N., Shahali, Y., & Dadar, M. (2020) · Beneficial Microbes · doi:10.3920/bm2019.0121 · Cited by 35
Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy
Wang, S., & Rong, L. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.06.042 · Cited by 35
Novel role of UHRF1 in the epigenetic repression of the latent HIV-1
Verdikt, R., Bendoumou, M., Bouchat, S., Nestola, L., Pasternak, A. O., Darcis, G., Avettand-Fènoël, V., Vanhulle, C., Aït-Ammar, A., Santangelo, M., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103985 · Cited by 34
Immune Reconstitution Inflammatory Syndrome (IRIS): What pathologists should know
Nelson, A. M., Manabe, Y. C., & Lucas, S. B. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2017.04.010 · Cited by 34
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Hegde, U. P., & Mukherji, B. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2007-x · Cited by 33
Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages
Lavigne, C., Guedj, A.-S., Kell, A. J., Barnes, M., Stals, S., Gonçalves, D., & Girard, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s82205 · Cited by 32
A Parallel Synthesis Approach to the Identification of Novel Diheteroarylamide-Based Compounds Blocking HIV Replication: Potential Inhibitors of HIV-1 Pre-mRNA Alternative Splicing
Cheung, P. K., Horhant, D., Bandy, L. E., Zamiri, M., Rabea, S. M., Karagiosov, S. K., Matloobi, M., McArthur, S., Harrigan, P. R., Chabot, B., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01357 · Cited by 32
The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy
Zhang, G., Guo, D., Dash, P. K., Araínga, M., Wiederin, J. L., Haverland, N. A., Knibbe, J., Martinez-Skinner, A., Ciborowski, P. S., Goodfellow, V. S., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.09.009 · Cited by 31
rigrag: high-resolution mapping of genic targeting preferences during HIV-1 integration in vitro and in vivo
Bedwell, G. J., Jang, S., Li, W., Singh, P. K., & Engelman, A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab514 · Cited by 28
eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients
Davis-Gardner, M. E., Gardner, M. R., Alfant, B., & Farzan, M. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006786 · Cited by 30
Latent HIV-1 Can Be Reactivated by Cellular Superinfection in a Tat-Dependent Manner, Which Can Lead to the Emergence of Multidrug-Resistant Recombinant Viruses
Donahue, D. A., Bastarache, S. M., Sloan, R. D., & Wainberg, M. A. (2013) · Journal of Virology · doi:10.1128/jvi.01165-13 · Cited by 29
Quantitation of integrated proviral DNA in viral reservoirs
Graf, E. H., & O’Doherty, U. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835d8132 · Cited by 28
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management
Nazari, I. S., & Feinstein, M. J. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00098-22 · Cited by 29
HIV-1 Preintegration Complex Preferentially Integrates the Viral DNA into Nucleosomes Containing Trimethylated Histone 3-Lysine 36 Modification and Flanking Linker DNA
Sapp, N., Burge, N. L., Cox, K. L., Thapa, S., Prakash, P., Balasubramaniam, M., Christensen, D. E., Li, M., Linderberger, J., Kvaratskhelia, M., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01011-22 · Cited by 31
Mapping the interplay between NK cells and HIV: therapeutic implications
Anderko, R. R., & Mailliard, R. B. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiac007 · Cited by 28
HIV Vaccines: A Brief Overview
Lema, D. A., García, A. H., & Sanctis, J. B. D. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12184 · Cited by 26
Impact of Antiretroviral Therapy Duration and Intensification on Isolated Shedding of HIV-1 RNA in Semen
Osborne, B., Sheth, P. M., Yi, T. J., Kovacs, C. C., Benko, E., la Porte, C., Huibner, S., Le, A. Q., Danroth, R., Baraki, B., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit026 · Cited by 26
Cytotoxicity assessment, inflammatory properties, and cellular uptake of Neutraplex lipid-based nanoparticles in THP-1 monocyte-derived macrophages
Berger, E., Breznan, D., Stals, S., Jasinghe, V. J., Gonçalves, D., Girard, D., Faucher, S., Vincent, R., Thierry, A. R., & Lavigne, C. (2017) · Nanobiomedicine · doi:10.1177/1849543517746259 · Cited by 26
Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking
Mukadam, I. Z., Machhi, J., Herskovitz, J., Hasan, M., Oleynikov, M. D., Blomberg, W. R., Svechkarev, D. A., Mohs, A. M., Zhou, Y., Dash, P. K., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119669 · Cited by 27
HIV/AIDS
Capriotti, T. (2018) · Home Healthcare Now · doi:10.1097/nhh.0000000000000706 · Cited by 25
Dynamical analysis of HIV-TB co-infection transmission model in the presence of treatment for TB
Bolaji, B., Onoja, T., Agbata, C., Omede, B. I., & Odionyenma, U. B. (2024) · Bulletin of Biomathematics · doi:10.59292/bulletinbiomath.2024002 · Cited by 23
An overview of intracellular interactions between immunodeficiency viruses and their hosts
Bieniasz, P. D. (2012) · AIDS · doi:10.1097/qad.0b013e328353bd04 · Cited by 22
Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch
Venkatachari, N. J., Zerbato, J. M., Jain, S., Mancini, A. E., Chattopadhyay, A., Sluis‐Cremer, N., Bar‐Joseph, Z., & Ayyavoo, V. (2015) · Retrovirology · doi:10.1186/s12977-015-0211-3 · Cited by 21
Practical considerations for developing nucleoside reverse transcriptase inhibitors
Hurwitz, S. J., & Schinazi, R. F. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.09.003 · Cited by 21
Innate immunity in the control of HIV/AIDS
Ploquin, M. J.-Y., Jacquelin, B., Jochems, S. P., Barré‐Sinoussi, F., & Müller-Trutwin, M. C. (2012) · AIDS · doi:10.1097/qad.0b013e328353e46b · Cited by 23
Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design
Chen, W., Ying, T., & Dimitrov, D. S. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.761969 · Cited by 21
Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus
Méndez, C. (2015) · World Journal of Virology · doi:10.5501/wjv.v4.i3.219 · Cited by 23
Fighting HIV-1 Persistence: At the Crossroads of “Shoc-K and B-Lock”
Acchioni, C., Palermo, E., Sandini, S., Acchioni, M., Hiscott, J. B., & Sgarbanti, M. (2021) · Pathogens · doi:10.3390/pathogens10111517 · Cited by 18
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects
Scherrer, D., Rouzier, R., Barrett, P. N., Steens, J.-M., Gineste, P., Murphy, R. L., Tazi, J., & Ehrlich, H. J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw458 · Cited by 20
Awareness of Cancer Risk Factors and Its Signs and Symptoms in Northern Tanzania: a Cross-Sectional Survey in the General Population and in People Living with HIV
Munishi, O. M., McCormack, V., Mchome, B. L., Mangi, G., Zullig, L. L., Bartlett, J. A., Mapunda, O., Nyindo, P., Namwai, T., Muiruri, C., et al. (2019) · Journal of Cancer Education · doi:10.1007/s13187-019-01513-6 · Cited by 20
Association of Inflammatory Cytokines and Endothelial Adhesion Molecules with Immunological, Virological, and Cardiometabolic Disease in HIV-Infected Individuals
Lacerda, H. R., Falcão, M. D. C. C., de Albuquerque, V. M. G., Zírpoli, J. C., Miranda-Filho, D. D. B., de Albuquerque, M. D. F. P. M., Montarroyos, U. R., & Ximenes, R. A. D. A. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0029 · Cited by 19
Platelets and Erythrocyte-Bound Platelets Bind Infectious HIV-1 in Plasma of Chronically Infected Patients
Beck, Z., Jagodzinski, L. L., Eller, M. A., Thelian, D., Matyas, G. R., Kunz, A. N., & Alving, C. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081002 · Cited by 18
Is specific HIV eradication from the brain possible or needed?
Brew, B. J., Gray, L. R., Lewin, S. R., & Churchill, M. J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.748029 · Cited by 17
The complex role of extracellular vesicles in HIV infection
Lee, J. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0073 · Cited by 17
Progress in understanding oral health and HIV / AIDS
Patton, L. L. (2013) · Oral Diseases · doi:10.1111/odi.12220 · Cited by 17
Feline immunodeficiency virus latency
McDonnel, S. J., Sparger, E. E., & Murphy, B. G. (2013) · Retrovirology · doi:10.1186/1742-4690-10-69 · Cited by 17
Genotypes and Transmitted Drug Resistance among Treatment-Naive HIV-1-Infected Patients in a Northwestern Province, China: Trends from 2003 to 2013
Zhao, K. Z., Kang, W., Liu, Q., Li, Y., Liu, Q., Jiang, W., Zhuang, Y., Guo, Z., Yu, Z., Li, X., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109821 · Cited by 17
Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults
Spitsin, S. V., Tebas, P., Barrett, J. S., Pappa, V., Kim, D., Taylor, D. M., Evans, D. L., & Douglas, S. D. (2017) · JCI Insight · doi:10.1172/jci.insight.95893 · Cited by 17
Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research
Denton, P. W., Søgaard, O. S., & Tolstrup, M. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0807-y · Cited by 17
Tracking replication-competent HIV reservoirs in infected individuals
Chun, T. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835d6e1c · Cited by 16
Self-citation
Gene-expression reversal of lncRNAs and associated mRNAs expression in active vs latent HIV infection
Nair, M., Sagar, V., & Pilakka‐Kanthikeel, S. (2016) · Scientific Reports · doi:10.1038/srep34862 · Cited by 15
Large Variations in HIV-1 Viral Load Explained by Shifting-Mosaic Metapopulation Dynamics
Lythgoe, K., Blanquart, F., Pellis, L., & Fraser, C. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002567 · Cited by 16
Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance
Olivetta, E., Chiozzini, C., Arenaccio, C., Manfredi, F., Ferrantelli, F., & Federico, M. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.12.006 · Cited by 16
Synthesis of Novel 3-(5-(Alkyl/arylthio)-1,3,4-Oxadiazol-2-yl)-8-Phenylquinolin-4(1H)-One Derivatives as Anti-HIV Agents
Parizadeh, N., Alipour, E., Soleymani, S., Zabihollahi, R., Aghasadeghi, M. R., Hajimahdi, Z., & Zarghi, A. (2017) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426507.2017.1394302 · Cited by 16
Synthetic approaches and application of clinically approved small-molecule Anti-HIV drugs: An update
Sun, L., Nie, P., Li, L., Herdewijn, P. A., & Wang, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115847 · Cited by 16
Achieving an AIDS-free world: science and implementation
Fauci, A. S., & Marston, H. D. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62042-5 · Cited by 15
Self-citation
Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment
Gutiérrez, C., Hernández‐Novoa, B., Vallejo, A., Villar, S. S., Abad-Fernández, M., Madrid, N., Díaz, L., Moreno, A. M., Dronda, F., Zamora, J., et al. (2013) · AIDS · doi:10.1097/qad.0b013e328361d0e1 · Cited by 15
Dendronized Gold Nanoparticles as Carriers for gp160 (HIV-1) Peptides: Biophysical Insight into Complex Formation
Garaiová, Z., Melikishvili, S., Michlewska, S., Йонов, М., Pędziwiatr‐Werbicka, E., Waczulı́ková, I., Hianik, T., Gómez, R., de la Mata, F. J., & Bryszewska, M. J. (2021) · Langmuir · doi:10.1021/acs.langmuir.0c03159 · Cited by 15
Blue Monday: Co-occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis
Chahine, A., Koru‐Sengul, T., Feaster, D. J., Dilworth, S. E., Antoni, M. H., Klatt, N. R., Roach, M. E., Pallikkuth, S., Sharkey, M. E., Salinas, J., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002560 · Cited by 15
The Immunology of Human Immunodeficiency Virus Infection
Moir, S. L., Connors, M., & Fauci, A. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00123-5 · Cited by 16
Self-citation
Achieving an AIDS-free World: Science and Implementation
Fauci, A. S., & Marston, H. D. (2013) · Cell · doi:10.1016/j.cell.2013.10.016 · Cited by 14
Self-citation
The HIV ‐1 gp41 ectodomain is cleaved by matriptase to produce a chemotactic peptide that acts through FPR 2
Wood, M. P., Cole, A. L., Eade, C. R., Chen, L., Chai, K. X., & Cole, A. M. (2014) · Immunology · doi:10.1111/imm.12278 · Cited by 14
Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects
Scherrer, D., Rouzier, R., Cardona, M., Barrett, P. N., Steens, J.-M., Gineste, P., Murphy, R. L., Tazi, J., & Ehrlich, H. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-16 · Cited by 14
Behavioral Decision Research Intervention Reduces Risky Sexual Behavior
Downs, J. S., de Bruin, W. B., Fischhoff, B., & Murray, P. J. (2015) · Current HIV Research · doi:10.2174/1570162x13666150511145328 · Cited by 14
Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood
Bailón, L., Puertas, M. C., García-Guerrero, M. C., Moraes-Cardoso, I., Aparicio, E., Alarcón‐Soto, Y., Rivero, À., Rosen, E. P., Estes, J. D., Blanco, J., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae530 · Cited by 13
Disclosure and Experienced Social Support are not Related to Anxiety or Depression in a German HIV Patient Cohort
Kittner, J. M., Brokamp, F., Thomaidis, T., Schmidt, R. E., Wiltink, J., Galle, P. R., & Jäger, B. (2014) · Infection and Chemotherapy · doi:10.3947/ic.2014.46.2.77 · Cited by 14

Authors: Chun, T.-W., & Fauci, A. S.
Affiliations: National Institutes of Health (US)
Corresponding author: Chun, Tae-Wook
ORCID: Chun, Tae-Wook
Fauci, Anthony S.
Venue: AIDS
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2012-06-19
Volume: 26
Issue: 10
Pages: 1261-1268
ISSN: 0269-9370 (ISSN-L)
DOI: 10.1097/qad.0b013e328353f3f1
OpenAlex: W2044293862
Cited by: 175
References: 99
Citations by year: 2026: 4 · 2025: 5 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 10 · 2018: 9 · 2017: 11 · 2016: 21 · 2015: 18 · 2014: 13 · 2013: 34 · 2012: 8
FWCI: 2.90
Type: journal article
Language: en
Open access: closed
Locations: AIDS (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: HIV reservoir, persistent HIV infection, antiretroviral therapy, viral eradication, lymphoid tissue, HIV pathogenesis
MeSH terms: Disease Reservoirs, Humans, Viremia, CD4-Positive T-Lymphocytes, HIV-1, HIV Infections, Virus Latency, Anti-Retroviral Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

HIV reservoirs: pathogenesis and obstacles to viral eradication and cure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks